NasdaqGS - Nasdaq Real Time Price USD

Zynex, Inc. (ZYXI)

2.1500

+0.0800

+(3.86%)

At close: May 12 at 4:00:02 PM EDT

Zynex Submits FDA Application for Its NiCO Laser Pulse Oximeter

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today announced it has submitted a 510(k) application to the U.S. Food and Drug Administration ("FDA") for its NiCO™, Noninvasive CO-Oximeter device.

PR Newswire 19 hours ago

ZYXI
+3.86%
The Consensus EPS Estimates For Zynex, Inc. (NASDAQ:ZYXI) Just Fell Dramatically

The analysts covering Zynex, Inc. ( NASDAQ:ZYXI ) delivered a dose of negativity to shareholders today, by making a...

Simply Wall St. 8 days ago

ZYXI
+3.86%
Q1 2025 Zynex Inc Earnings Call

Q1 2025 Zynex Inc Earnings Call

Thomson Reuters StreetEvents 12 days ago

ZYXI
+3.86%
Zynex Inc (ZYXI) Q1 2025 Earnings Call Highlights: Navigating Revenue Challenges and Strategic ...

Zynex Inc (ZYXI) faces a revenue decline but remains optimistic with new growth strategies and product launches on the horizon.

GuruFocus.com 13 days ago

ZYXI
+3.86%
Zynex Inc. (ZYXI) Reports Q1 Loss, Lags Revenue Estimates

Zynex (ZYXI) delivered earnings and revenue surprises of -65% and 15.63%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?

Zacks 13 days ago

ZYXI
+3.86%
Zynex Reports First Quarter 2025 Financial Results

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported its financial and operational results for the first quarter ended March 31, 2025.

PR Newswire 13 days ago

ZYXI
+3.86%
Zynex, Inc. (NASDAQ:ZYXI) Delivered A Weaker ROE Than Its Industry

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

Simply Wall St. 16 days ago

ZYXI
+3.86%
Zynex Sets First Quarter 2025 Earnings Call

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on Tuesday, April 29, 2025 at 4:15 PM Eastern Time to discuss its financial results for the first quarter ended March 31, 2025. Financial results will be issued in a press release prior to the call.

PR Newswire 20 days ago

ZYXI
+3.86%
Zynex (NASDAQ:ZYXI) investors are sitting on a loss of 80% if they invested a year ago

The art and science of stock market investing requires a tolerance for losing money on some of the shares you buy. But...

Simply Wall St. last month

ZYXI
+3.86%
Zynex, Inc. Just Missed EPS By 55%: Here's What Analysts Think Will Happen Next

Zynex, Inc. ( NASDAQ:ZYXI ) just released its latest full-year report and things are not looking great. It wasn't a...

Simply Wall St. last month

ZYXI
+3.86%
Top Midday Decliners

Zynex (ZYXI) shares slumped 49% amid heavy trading after the company reported late Tuesday it swung

PREMIUM
MT Newswires last month

ZYXI
+3.86%

IRBT
Q4 2024 Zynex Inc Earnings Call

Q4 2024 Zynex Inc Earnings Call

Thomson Reuters StreetEvents last month

ZYXI
+3.86%
Zynex Inc (ZYXI) Q4 2024 Earnings Call Highlights: Navigating Challenges and Opportunities

Despite a net loss and TRICARE payment suspension, Zynex Inc (ZYXI) shows resilience with revenue growth and strategic restructuring.

GuruFocus.com 2 months ago

ZYXI
+3.86%
Zynex Inc. (ZYXI) Reports Q4 Loss, Misses Revenue Estimates

Zynex (ZYXI) delivered earnings and revenue surprises of -122.22% and 14.39%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

Zacks 2 months ago

ZYXI
+3.86%
Zynex Reports Fourth Quarter and Full Year 2024 Financial Results

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, today reported its financial and operational results for the fourth quarter and full year ended December 31, 2024.

PR Newswire 2 months ago

ZYXI
+3.86%
Is There Now An Opportunity In Zynex, Inc. (NASDAQ:ZYXI)?

Zynex, Inc. ( NASDAQ:ZYXI ), is not the largest company out there, but it saw significant share price movement during...

Simply Wall St. 2 months ago

ZYXI
+3.86%
Zynex Sets Fourth Quarter and Year End 2024 Earnings Call

Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, will hold a conference call on Tuesday, March 11, 2025 at 4:15 PM Eastern Time to discuss its financial results for the fourth quarter and year ended December 31, 2024. Financial results will be issued in a press release prior to the call.

PR Newswire 2 months ago

ZYXI
+3.86%
With 47% ownership, Zynex, Inc. (NASDAQ:ZYXI) insiders have a lot at stake

Key Insights Zynex's significant insider ownership suggests inherent interests in company's expansion The top 3...

Simply Wall St. 2 months ago

ZYXI
+3.86%
Returns On Capital Signal Tricky Times Ahead For Zynex (NASDAQ:ZYXI)

Finding a business that has the potential to grow substantially is not easy, but it is possible if we look at a few key...

Simply Wall St. 3 months ago

ZYXI
+3.86%
3 US Stocks Estimated To Be Trading Up To 32.9% Below Intrinsic Value

As the U.S. stock market faces turbulence with major indices like the Dow and S&P 500 experiencing significant declines, investors are keenly observing opportunities that might arise from current valuations. In such a volatile environment, identifying stocks that trade below their intrinsic value can present potential investment opportunities, as these may offer room for appreciation when market conditions stabilize.

Simply Wall St. 4 months ago

ZYXI
+3.86%

GHLD

INFN

Performance Overview

Return	ZYXI	S&P 500 (^GSPC)
YTD	-73.16%	-0.64%
1-Year	-79.50%	+11.90%
3-Year	-67.67%	+48.70%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Zynex, Inc. (ZYXI)

Zynex Submits FDA Application for Its NiCO Laser Pulse Oximeter

The Consensus EPS Estimates For Zynex, Inc. (NASDAQ:ZYXI) Just Fell Dramatically

Q1 2025 Zynex Inc Earnings Call

Zynex Inc (ZYXI) Q1 2025 Earnings Call Highlights: Navigating Revenue Challenges and Strategic ...

Zynex Inc. (ZYXI) Reports Q1 Loss, Lags Revenue Estimates

Zynex Reports First Quarter 2025 Financial Results

Zynex, Inc. (NASDAQ:ZYXI) Delivered A Weaker ROE Than Its Industry

Zynex Sets First Quarter 2025 Earnings Call

Zynex (NASDAQ:ZYXI) investors are sitting on a loss of 80% if they invested a year ago

Zynex, Inc. Just Missed EPS By 55%: Here's What Analysts Think Will Happen Next

Top Midday Decliners

Q4 2024 Zynex Inc Earnings Call

Zynex Inc (ZYXI) Q4 2024 Earnings Call Highlights: Navigating Challenges and Opportunities

Zynex Inc. (ZYXI) Reports Q4 Loss, Misses Revenue Estimates

Zynex Reports Fourth Quarter and Full Year 2024 Financial Results

Is There Now An Opportunity In Zynex, Inc. (NASDAQ:ZYXI)?

Zynex Sets Fourth Quarter and Year End 2024 Earnings Call

With 47% ownership, Zynex, Inc. (NASDAQ:ZYXI) insiders have a lot at stake

Returns On Capital Signal Tricky Times Ahead For Zynex (NASDAQ:ZYXI)

3 US Stocks Estimated To Be Trading Up To 32.9% Below Intrinsic Value

Performance Overview